Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GPAT
GPAT logo

GPAT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy GP-Act III Acquisition Corp (GPAT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
10.820
1 Day change
52 Week Range
10.830
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

GP-Act III Acquisition Corp (GPAT) is not a strong buy at this time for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows no significant upward momentum or compelling catalysts to justify immediate action. It is better to hold off on investing until more positive signals or catalysts emerge.

Technical Analysis

The technical indicators show a neutral to slightly bullish trend. The MACD histogram is positive and expanding, indicating mild bullish momentum. The RSI is at 65.628, which is neutral and does not suggest overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the price is trading very close to its pivot level of 10.805, showing limited movement potential.

Positive Catalysts

  • The stock has an 80% chance to increase by 0.81% in the next day, 1.74% in the next week, and 12.63% in the next month, based on similar candlestick patterns. The MACD and moving averages are mildly bullish.

Neutral/Negative Catalysts

  • is down by -1.79%, which may indicate a bearish sentiment in the market. The company's financial performance in Q3 2025 shows declining net income (-15.06% YoY) and EPS (-10.00% YoY), with no revenue growth.

Financial Performance

In Q3 2025, the company's revenue remained at 0 with no growth. Net income decreased by -15.06% YoY to 3,105,859, and EPS dropped by -10.00% YoY to 0.09. Gross margin remained unchanged at 0.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes are available for this stock.

Wall Street analysts forecast GPAT stock price to rise
Analyst Rating
0
Wall Street analysts forecast GPAT stock price to rise
Buy
Hold
Sell
0
Current: 10.820
sliders
Low
0
Averages
0
High
0
0
Current: 10.820
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch